| Pharmaceutical Information |
| Drug Name |
Alcaftadine |
| Drug ID |
BADD_D00058 |
| Description |
Alcaftadine is a H1 histamine receptor antagonist indicated for the prevention of itching associated with allergic conjunctivitis. This drug was approved in July 2010. |
| Indications and Usage |
For the prevention of itching associated with allergic conjunctivitis. |
| Marketing Status |
Prescription |
| ATC Code |
S01GX11 |
| DrugBank ID |
DB06766
|
| KEGG ID |
D06552
|
| MeSH ID |
C557708
|
| PubChem ID |
19371515
|
| TTD Drug ID |
D0O7JW
|
| NDC Product Code |
12502-5263; 0023-4291; 14501-0020; 0023-4290; 42973-204 |
| Synonyms |
alcaftadine |
|
| Chemical Information |
| Molecular Formula |
C19H21N3O |
| CAS Registry Number |
147084-10-4 |
| SMILES |
CN1CCC(=C2C3=CC=CC=C3CCN4C2=NC=C4C=O)CC1 |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
